ASTROMICS
DEAD

Serial Number

98145437

Owner

Cosmica Inc

Attorney

Peter Jensen-Haxel

Filing Date

Aug 22, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ASTROMICS Trademark

Serial Number: 98145437

ASTROMICS is a trademark filed by Cosmica Inc on August 22, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Cosmica Inc (4 trademarks)

[email protected]
San Francisco, CA 94107

Entity Type: 03

Trademark Details

Filing Date

August 22, 2023

Registration Date

Not Registered

Goods & Services

Pharmaceutical drug development services; Scientific research; Biological research; Biotechnology research; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development in the pharmaceutical and biotechnology fields; Development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consulting services in the field of pharmaceutical research Testing, inspection, research, or development of pharmaceutical preparations for gene therapy treatment of low gravity and micro gravity induced illness and related conditions; Laboratory analysis in the field of aging, low gravity exposure, cellular senescence, fibrosis, inflammation, cytokine production, immunosenescence, cytoskeleton, oxidative stress, and mitochondrial dysfunction

Arranging and conducting of seminars and workshops in the field of space travel, manned spaceflight, and low gravity and micro gravity exposure; Arranging and conducting of seminars and workshops in the field of aging, accelerated aging, and simulated aging; Providing information related to space travel, manned spaceflight, and low gravity and micro gravity exposure; Providing information related to aging, accelerated aging, and simulated aging

Nutraceuticals for use as a dietary supplement; Dietary supplements for human consumption; Pharmaceutical preparations, namely, anti-aging treatments; Pharmaceutical preparations, namely, treatments for gene expression reversal and normalization; Pharmaceutical preparations, namely, medications and treatments for low gravity and space-induced illness; Pharmaceutical preparations for the prevention and treatment of low gravity and micro gravity induced illness and related conditions; Pharmaceutical preparations for the prevention and treatment of cellular senescence, fibrosis, inflammation, cytokine production, immunosenescence, cytoskeleton, oxidative stress, and mitochondrial dysfunction

Providing healthcare and medical information; Pharmaceutical compounding services; Technical consulting in the field of pharmaceutical studies; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of diagnostic medical testing and nutrition; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical testing in the field of aging, low gravity exposure, cellular senescence, fibrosis, inflammation, cytokine production, immunosenescence, cytoskeleton, oxidative stress, and mitochondrial dysfunction

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 10, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 10, 2024 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 29, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 29, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 2, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 2, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 2, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2023 NWOS
NEW APPLICATION ENTERED
Aug 25, 2023 NWAP